The FDA’s committee recommended the Novavax vaccine for use in the U.S. on Tuesday. Post navigation FDA decision on Novavax’s Covid shots could be delayed to review changes in manufacturing Nio reports wider first-quarter loss as Covid shutdowns in China hamper deliveries